{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:50:30Z","timestamp":1790635830821,"version":"4.1.0"},"reference-count":248,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurophysiologie Clinique\/Clinical Neurophysiology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.neucli.2017.02.004","type":"journal-article","created":{"date-parts":[[2017,4,23]],"date-time":"2017-04-23T00:30:26Z","timestamp":1492907426000},"page":"139-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":143,"title":["Fatigue in multiple sclerosis \u2013 Insights into evaluation and management"],"prefix":"10.1016","volume":"47","author":[{"given":"Samar S.","family":"Ayache","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moussa A.","family":"Chalah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neucli.2017.02.004_bib1000","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1345\/aph.17279","article-title":"Pemoline therapy resulting in liver transplantation","volume":"32","author":"Adcock","year":"1998","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.neucli.2017.02.004_bib1005","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1007\/s00415-015-7797-1","article-title":"Sustained-released fampridine in multiple sclerosis: effects on gait parameters, arm function, fatigue, and quality of life","volume":"262","author":"Allart","year":"2015","journal-title":"J Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1010","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.1468-1331.2009.02776.x","article-title":"Fatigue and processing speed are related in multiple sclerosis","volume":"17","author":"Andreasen","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1015","first-page":"428","article-title":"Does amantadine have favourable effects on fatigue in Persian patients suffering from multiple sclerosis?","volume":"43","author":"Ashtari","year":"2009","journal-title":"Neurol Neurochir Pol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1020","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/1352458506071162","article-title":"The relationship between subjective fatigue and cognitive fatigue in advanced multiple sclerosis","volume":"13","author":"Bailey","year":"2007","journal-title":"Mult Scler"},{"key":"10.1016\/j.neucli.2017.02.004_bib1025","doi-asserted-by":"publisher","first-page":"811","DOI":"10.2174\/138920006778520561","article-title":"Oral L-carnitine: metabolite formation and hemodialysis","volume":"7","author":"Bain","year":"2006","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.neucli.2017.02.004_bib1030","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1212\/WNL.53.5.1151","article-title":"Fatigue in multiple sclerosis: cross-sectional correlation with brain MRI findings in 71\u00a0patients","volume":"53","author":"Bakshi","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neucli.2017.02.004_bib1035","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1556\/AMicr.50.2003.4.3","article-title":"Increased levels of tumor necrosis alpha and soluble vascular endothelial adhesion molecule-1 in the cerebrospinal fluid of patients with connective tissue diseases and multiple sclerosis","volume":"50","author":"Baraczka","year":"2003","journal-title":"Acta Microbiol Immunol Hung"},{"key":"10.1016\/j.neucli.2017.02.004_bib1040","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/S0140-6736(85)92413-4","article-title":"Non-invasive magnetic stimulation of human motor cortex","volume":"1","author":"Barker","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.neucli.2017.02.004_bib1045","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jns.2005.03.003","article-title":"Sodium-mediated axonal degeneration in inflammatory demyelinating disease","volume":"233","author":"Bechtold","year":"2005","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neucli.2017.02.004_bib1050","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jns.2004.12.009","article-title":"Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change","volume":"231","author":"Benedict","year":"2005","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neucli.2017.02.004_bib1055","first-page":"A356","article-title":"Cytokine correlates of fatigue in multiple sclerosis","volume":"43","author":"Bertolone","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.neucli.2017.02.004_bib1060","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1177\/1352458516628331","article-title":"Fatigue in multiple sclerosis: the contribution of occult white matter damage","volume":"22","author":"Bisecco","year":"2016","journal-title":"Mult Scler"},{"key":"10.1016\/j.neucli.2017.02.004_bib1065","doi-asserted-by":"publisher","first-page":"e0151288","DOI":"10.1371\/journal.pone.0151288","article-title":"Cerebrospinal Fluid Hypocretin-1 (orexin-A) level fluctuates with season and correlates with day length","volume":"11","author":"Boddum","year":"2016","journal-title":"Plos One"},{"key":"10.1016\/j.neucli.2017.02.004_bib1070","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1046\/j.1471-4159.1997.68062227.x","article-title":"Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases","volume":"68","author":"Bola\u00f1os","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.neucli.2017.02.004_bib1075","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1093\/sleep\/33.8.1061","article-title":"Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment","volume":"33","author":"Braley","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/j.neucli.2017.02.004_bib1080","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.smrv.2009.07.005","article-title":"Sleep disorders in patients with multiple sclerosis","volume":"14","author":"Brass","year":"2010","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.neucli.2017.02.004_bib1085","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jns.2015.05.006","article-title":"Impaired sleep-associated modulation of post-exercise corticomotor depression in multiple sclerosis","volume":"354","author":"Bridoux","year":"2015","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neucli.2017.02.004_bib1090","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000232927","article-title":"Effect of modafinil on subjective fatigue in multiple sclerosis and stroke patients","volume":"62","author":"Brioschi","year":"2009","journal-title":"Eur Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1095","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1212\/WNL.49.2.444","article-title":"Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy","volume":"49","author":"Broughton","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.neucli.2017.02.004_bib1100","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/1471-2377-12-161","article-title":"An exploration of impaired walking dynamics and fatigue in multiple sclerosis","volume":"12","author":"Burschka","year":"2012","journal-title":"BMC Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1105","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1177\/1352458510376405","article-title":"Basal ganglia and frontal\/parietal cortical atrophy is associated with fatigue in relapsing-remitting multiple sclerosis","volume":"16","author":"Calabrese","year":"2010","journal-title":"Mult Scler"},{"key":"10.1016\/j.neucli.2017.02.004_bib1110","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/cdd.2009.179","article-title":"The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis","volume":"17","author":"Centonze","year":"2010","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.neucli.2017.02.004_bib1115","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3389\/fncel.2015.00460","article-title":"Fatigue in multiple sclerosis: neural correlates and the role of non-invasive brain stimulation","volume":"9","author":"Chalah","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.neucli.2017.02.004_bib1120","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jns.2016.11.015","article-title":"Effects of left DLPFC versus right PPC tDCS on multiple sclerosis fatigue","volume":"372","author":"Chalah","year":"2017","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neucli.2017.02.004_bib1125","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0022-3999(93)90081-P","article-title":"Development of a fatigue scale","volume":"37","author":"Chalder","year":"1993","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.neucli.2017.02.004_bib1130","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0022-510X(00)00411-1","article-title":"Fatigue and basal ganglia","volume":"179","author":"Chaudhuri","year":"2000","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neucli.2017.02.004_bib1135","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.clinph.2007.10.014","article-title":"The clinical diagnostic utility of transcranial magnetic stimulation: report of an IFCN committee","volume":"119","author":"Chen","year":"2008","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1140","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1017\/S0317167100042360","article-title":"Amantadine treatment for refractory pain and fatigue in patients with multiple sclerosis","volume":"19","author":"Chiba","year":"1992","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.neucli.2017.02.004_bib1145","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1016\/j.rehab.2016.07.093","article-title":"\u201cGait responder\u201d to fampridine, a too restrictive concept?","volume":"59S","author":"Christopher","year":"2016","journal-title":"Ann Phys Rehabil Med"},{"key":"10.1016\/j.neucli.2017.02.004_bib1150","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.dld.2007.06.013","article-title":"L-Carnitine in the treatment of fatigue in adult celiac disease patients: a pilot study","volume":"39","author":"Ciacci","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.neucli.2017.02.004_bib1155","first-page":"272","article-title":"Metabolite findings in tumefactive demyelinating lesions utilizing short echo time proton magnetic resonance spectroscopy","volume":"28","author":"Cianfoni","year":"2007","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1160","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1001\/archneur.1992.00530300077013","article-title":"Sleep disturbance depression, and lesion site in patients with multiple sclerosis","volume":"49","author":"Clark","year":"1992","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1165","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.neubiorev.2009.12.011","article-title":"The cortisol awakening response: more than a measure of HPA axis function","volume":"35","author":"Clow","year":"2010","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.neucli.2017.02.004_bib1170","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s004150200060","article-title":"A preliminary study of magnetization transfer and diffusion tensor MRI of multiple sclerosis patients with fatigue","volume":"249","author":"Codella","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1175","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1001\/archneur.1989.00520420096030","article-title":"Amantadine treatment of fatigue associated with multiple sclerosis","volume":"46","author":"Cohen","year":"1989","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1180","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1007\/s004150070148","article-title":"MRI and motor evoked potential findings in nondisabled multiple sclerosis patients with and without symptoms of fatigue","volume":"247","author":"Colombo","year":"2000","journal-title":"J Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1185","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1600-0404.1995.tb00145.x","article-title":"Fatigue in multiple sclerosis is associated with specific clinical features","volume":"92","author":"Colosimo","year":"1995","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.neucli.2017.02.004_bib1190","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.neucli.2017.02.004_bib1195","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jns.2011.04.024","article-title":"Orexin\u00a0A (hypocretin-1) levels are not reduced while cocaine\/amphetamine regulated transcript levels are increased in the cerebrospinal fluid of patients with multiple sclerosis: no correlation with fatigue and sleepiness","volume":"307","author":"Constantinescu","year":"2011","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neucli.2017.02.004_bib1200","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1177\/1352458505070609","article-title":"Gait variability in people with multiple sclerosis","volume":"12","author":"Crenshaw","year":"2006","journal-title":"Mult Scler"},{"key":"10.1016\/j.neucli.2017.02.004_bib1205","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1196\/annals.1320.016","article-title":"L-carnitine supplementation for the treatment of fatigue and depressed mood in cancer patients with carnitine deficiency: a preliminary analysis","volume":"1033","author":"Cruciani","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neucli.2017.02.004_bib1210","doi-asserted-by":"publisher","first-page":"e77914","DOI":"10.1371\/journal.pone.0077914","article-title":"Regional brain atrophy and functional connectivity changes related to fatigue in multiple sclerosis","volume":"8","author":"Cruz G\u00f3mez \u00c1J","year":"2013","journal-title":"Plos One"},{"key":"10.1016\/j.neucli.2017.02.004_bib1215","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/ana.410270215","article-title":"Orally administered 4-aminopyridine improves clinical signs in multiple sclerosis","volume":"27","author":"Davis","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1220","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"de Lecea","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neucli.2017.02.004_bib1225","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1016\/j.rehab.2016.07.095","article-title":"Fatigue and gait speed in multiple sclerosis: assessment and relationship","volume":"59S","author":"De Pin","year":"2016","journal-title":"Ann Phys Rehabil Med"},{"key":"10.1016\/j.neucli.2017.02.004_bib1230","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jns.2008.01.018","article-title":"Neural correlates of cognitive fatigue in multiple sclerosis using functional MRI","volume":"270","author":"DeLuca","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neucli.2017.02.004_bib1235","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.msard.2013.03.005","article-title":"Fatigue is associated with metabolic and density alterations of cortical and deep gray matter in relapsing-remitting-multiple sclerosis patients at the earlier stage of the disease: a PET\/MR study","volume":"2","author":"Derache","year":"2013","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.neucli.2017.02.004_bib1240","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fneur.2015.00052","article-title":"The dopamine imbalance hypothesis of fatigue in multiple sclerosis and other neurological disorders","volume":"6","author":"Dobryakova","year":"2015","journal-title":"Front Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1245","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000026418","article-title":"Effects of the IL-1 receptor antagonist on the IL-1- and endotoxin-induced activation of the HPA axis and cerebral biogenic amines in mice","volume":"7","author":"Dunn","year":"2000","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.neucli.2017.02.004_bib1250","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/ana.20736","article-title":"Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients","volume":"59","author":"Dutta","year":"2006","journal-title":"Ann Neurol."},{"key":"10.1016\/j.neucli.2017.02.004_bib1255","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.pmr.2005.01.001","article-title":"Chronic pain in persons with multiple sclerosis","volume":"16","author":"Ehde","year":"2005","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"10.1016\/j.neucli.2017.02.004_bib1260","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.genhosppsych.2007.08.002","article-title":"Efficacy of paroxetine in treating major depressive disorder in persons with multiple sclerosis","volume":"30","author":"Ehde","year":"2008","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.neucli.2017.02.004_bib1265","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/brb3.181","article-title":"Thalamo-striato-cortical determinants to fatigue in multiple sclerosis","volume":"3","author":"Engstr\u00f6m","year":"2013","journal-title":"Brain Behav"},{"key":"10.1016\/j.neucli.2017.02.004_bib1270","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/0022-510X(94)90035-3","article-title":"Nocturnal sleep study in multiple sclerosis: correlations with clinical and brain magnetic resonance imaging findings","volume":"125","author":"Ferini-Strambi","year":"1994","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neucli.2017.02.004_bib1275","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3233\/NRE-131019","article-title":"Transcranial direct current stimulation (tDCS) for fatigue in multiple sclerosis","volume":"34","author":"Ferrucci","year":"2014","journal-title":"Neurorehabilitation"},{"key":"10.1016\/j.neucli.2017.02.004_bib1280","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1006\/nimg.2001.1011","article-title":"Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis","volume":"15","author":"Filippi","year":"2002","journal-title":"Neuroimage"},{"key":"10.1016\/j.neucli.2017.02.004_bib1285","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1177\/1352458514555784","article-title":"Altered basal ganglia functional connectivity in multiple sclerosis patients with fatigue","volume":"21","author":"Finke","year":"2014","journal-title":"Mult Scler"},{"key":"10.1016\/j.neucli.2017.02.004_bib1290","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1017\/S0317167100048691","article-title":"The impact of fatigue on patients with multiple sclerosis","volume":"21","author":"Fisk","year":"1994","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.neucli.2017.02.004_bib1295","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1191\/1352458502ms839oa","article-title":"Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters","volume":"8","author":"Flachenecker","year":"2002","journal-title":"Mult Scler"},{"key":"10.1016\/j.neucli.2017.02.004_bib1300","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1212\/01.WNL.0000080365.95436.B8","article-title":"Fatigue in MS is related to sympathetic vasomotor dysfunction","volume":"61","author":"Flachenecker","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neucli.2017.02.004_bib1305","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1191\/1352458504ms991oa","article-title":"Cytokine mRNA expression in patients with multiple sclerosis and fatigue","volume":"10","author":"Flachenecker","year":"2004","journal-title":"Mult Scler"},{"key":"10.1016\/j.neucli.2017.02.004_bib1310","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1055\/s-2005-867075","article-title":"Sleep disorders in multiple sclerosis","volume":"25","author":"Fleming","year":"2005","journal-title":"Semin Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1315","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0022-3999(98)00004-X","article-title":"The nature of fatigue in multiple sclerosis","volume":"45","author":"Ford","year":"1998","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.neucli.2017.02.004_bib1320","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1037\/a0039919","article-title":"Cognitive effects of modafinil in patients with multiple sclerosis: a clinical trial","volume":"61","author":"Ford-Johnson","year":"2016","journal-title":"Rehabil Psychol."},{"key":"10.1016\/j.neucli.2017.02.004_bib1325","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1136\/acupmed-2012-010199","article-title":"Amantadine and the place of acupuncture in the treatment of fatigue in patients with multiple sclerosis: an observational study","volume":"31","author":"Foroughipour","year":"2013","journal-title":"Acupunct Med"},{"key":"10.1016\/j.neucli.2017.02.004_bib1330","first-page":"135","article-title":"Symptomatic fatigue in multiple sclerosis","volume":"65","author":"Freal","year":"1984","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.neucli.2017.02.004_bib1335","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1152\/physrev.2001.81.4.1725","article-title":"Spinal and supraspinal factors in human muscle fatigue","volume":"81","author":"Gandevia","year":"2001","journal-title":"Physiol Rev"},{"key":"10.1016\/j.neucli.2017.02.004_bib1340","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1001\/archneur.1996.00550020101021","article-title":"The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis","volume":"53","author":"Geisler","year":"1996","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1345","doi-asserted-by":"publisher","first-page":"e78811","DOI":"10.1371\/journal.pone.0078811","article-title":"Examination of cognitive fatigue in multiple sclerosis using functional magnetic resonance imaging and diffusion tensor imaging","volume":"8","author":"Genova","year":"2013","journal-title":"Plos One"},{"key":"10.1016\/j.neucli.2017.02.004_bib1350","first-page":"424","article-title":"Transdermal histamine in multiple sclerosis: part one. Clinical experience","volume":"4","author":"Gillson","year":"1999","journal-title":"Alt Med Rev"},{"key":"10.1016\/j.neucli.2017.02.004_bib1355","first-page":"224","article-title":"Transdermal histamine in multiple sclerosis: part two. A proposed theoretical basis for its use","volume":"5","author":"Gillson","year":"2000","journal-title":"Alt Med Rev"},{"key":"10.1016\/j.neucli.2017.02.004_bib1360","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/135245850200800107","article-title":"A double-blind pilot study of the effect of prokarin on fatigue in multiple sclerosis","volume":"8","author":"Gillson","year":"2002","journal-title":"Mult Scler"},{"key":"10.1016\/j.neucli.2017.02.004_bib1365","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1177\/1352458513493684","article-title":"Influence of the topography of brain damage on depression and fatigue in patients with multiple sclerosis","volume":"20","author":"Gobbi","year":"2014","journal-title":"Mult Scler"},{"key":"10.1016\/j.neucli.2017.02.004_bib1370","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1177\/1352458514530022","article-title":"Forceps minor damage and co-occurrence of depression and fatigue in multiple sclerosis","volume":"20","author":"Gobbi","year":"2014","journal-title":"Mult Scler"},{"key":"10.1016\/j.neucli.2017.02.004_bib1375","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1136\/jnnp.2010.230029","article-title":"Endocrine and immune substrates of depressive symptoms and fatigue in multiple sclerosis patients with comorbid major depression","volume":"82","author":"Gold","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neucli.2017.02.004_bib1380","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jns.2008.06.029","article-title":"Neurodegeneration in multiple sclerosis: the role of oxidative stress and excitotoxicity","volume":"274","author":"Gonsette","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neucli.2017.02.004_bib1385","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1001\/archneur.62.2.277","article-title":"Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis","volume":"62","author":"Gottschalk","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1390","doi-asserted-by":"publisher","first-page":"11376","DOI":"10.1523\/JNEUROSCI.2311-11.2011","article-title":"Inflammation-induced lethargy is mediated by suppression of orexin neuron activity","volume":"31","author":"Grossberg","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.neucli.2017.02.004_bib1395","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1177\/1352458514549567","article-title":"Is there a cognitive signature for MS-related fatigue?","volume":"21","author":"Hanken","year":"2015","journal-title":"Mult Scler"},{"key":"10.1016\/j.neucli.2017.02.004_bib1400","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0306-4530(01)00071-3","article-title":"Cognitive impairment correlates with hypothalamo-pituitary-adrenal axis dysregulation in multiple sclerosis","volume":"27","author":"Heesen","year":"2002","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neucli.2017.02.004_bib1405","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1136\/jnnp.2005.065805","article-title":"Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?","volume":"77","author":"Heesen","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neucli.2017.02.004_bib1410","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.bbi.2010.05.006","article-title":"Correlates of cognitive dysfunction in multiple sclerosis","volume":"24","author":"Heesen","year":"2010","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.neucli.2017.02.004_bib1415","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1016\/j.apmr.2016.06.003","article-title":"Current evidence does not support exercise therapy for perceived fatigue in multiple sclerosis","volume":"97","author":"Heine","year":"2016","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.neucli.2017.02.004_bib1420","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1007\/s00259-014-2790-y","article-title":"Altered serotonin transporter availability in patients with multiple sclerosis","volume":"41","author":"Hesse","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.neucli.2017.02.004_bib1425","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4137\/JCNSD.S14049","article-title":"Efficacy and side effects of natalizumab therapy in patients with multiple sclerosis","volume":"6","author":"Hoepner","year":"2014","journal-title":"J Cent Nerv Syst Dis"},{"key":"10.1016\/j.neucli.2017.02.004_bib1430","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.apmr.2011.05.017","article-title":"Is there a relationship between fatigue questionnaires and gait mechanics in persons with multiple sclerosis?","volume":"92","author":"Huisinga","year":"2011","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.neucli.2017.02.004_bib1435","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1177\/1352458511412061","article-title":"The effects of rivastigmine on processing speed and brain activation in patients with multiple sclerosis and subjective cognitive fatigue","volume":"17","author":"Huolman","year":"2011","journal-title":"Mult Scler"},{"key":"10.1016\/j.neucli.2017.02.004_bib1440","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1001\/archneur.64.2.196","article-title":"Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility contrast perfusion magnetic resonance imaging at 3T","volume":"64","author":"Inglese","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1445","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1177\/135245859900500103","article-title":"The fatigue descriptive scale (FDS): a useful tool to evaluate fatigue in multiple sclerosis","volume":"5","author":"Iriarte","year":"1999","journal-title":"Mult Scler"},{"key":"10.1016\/j.neucli.2017.02.004_bib1450","doi-asserted-by":"crossref","first-page":"944","DOI":"10.5665\/sleep\/31.7.944","article-title":"Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study","volume":"31","author":"Italian REMS study group","year":"2008","journal-title":"Sleep"},{"key":"10.1016\/j.neucli.2017.02.004_bib1455","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"key":"10.1016\/j.neucli.2017.02.004_bib1460","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2169\/internalmedicine.42.743","article-title":"Hypersomnia and low CSF hypocretin-1 (orexin-A) concentration in a patient with multiple sclerosis showing bilateral hypothalamic lesions","volume":"42","author":"Kato","year":"2003","journal-title":"Intern Med"},{"key":"10.1016\/j.neucli.2017.02.004_bib1465","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/mus.880170802","article-title":"Postexercise phos-phocreatine resynthesis is slowed in multiple sclerosis","volume":"17","author":"Kent-Braun","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neucli.2017.02.004_bib1470","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1002\/mus.880171006","article-title":"Effects of exercise on muscle activation and metabolism in multiple sclerosis","volume":"17","author":"Kent-Braun","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neucli.2017.02.004_bib1475","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1152\/jappl.1997.83.6.1998","article-title":"Strength, skeletal muscle composition, and enzyme activity in multiple sclerosis","volume":"83","author":"Kent-Braun","year":"1997","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.neucli.2017.02.004_bib1480","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S0165-5728(99)00184-8","article-title":"Reduction of both pro- and anti-inflammatory cytokines after 6\u00a0months of interferon beta-1a treatment of multiple sclerosis","volume":"103","author":"Khademi","year":"2000","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1485","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1523\/JNEUROSCI.22-13-05282.2002","article-title":"Release of hypocretin (orexin) during waking and sleep states","volume":"22","author":"Kiyashchenko","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.neucli.2017.02.004_bib1490","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/J003v17n03_04","article-title":"Self-report assessment of fatigue in multiple sclerosis: a critical evaluation","volume":"17","author":"Kos","year":"2004","journal-title":"Occup Ther Health Care"},{"key":"10.1016\/j.neucli.2017.02.004_bib1495","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1191\/1352458505ms1117oa","article-title":"Evaluation of the modified fatigue impact scale in four different European countries","volume":"11","author":"Kos","year":"2005","journal-title":"Mult Scler"},{"key":"10.1016\/j.neucli.2017.02.004_bib1500","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1471-2377-6-27","article-title":"A rapid screening tool for fatigue impact in multiple sclerosis","volume":"6","author":"Kos","year":"2006","journal-title":"BMC Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1505","series-title":"The most common complaints: fatigue","author":"Krupp","year":"2003"},{"key":"10.1016\/j.neucli.2017.02.004_bib1510","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/00019052-199612000-00011","article-title":"Mechanisms and management of fatigue in progressive neurological disorders","volume":"9","author":"Krupp","year":"1996","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1515","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1001\/archneur.1988.00520280085020","article-title":"Fatigue in multiple sclerosis","volume":"45","author":"Krupp","year":"1988","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1520","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","article-title":"The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus","volume":"46","author":"Krupp","year":"1989","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1525","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1212\/WNL.45.11.1956","article-title":"Fatigue therapy in multiple sclerosis: results of a double blind, randomized, parallel trial of amantadine, pemoline, and placebo","volume":"45","author":"Krupp","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.neucli.2017.02.004_bib1530","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.psyneuen.2014.03.012","article-title":"Hypothalamo-pituitary-adrenal axis activity evolves differentially in untreated versus treated multiple sclerosis","volume":"45","author":"K\u00fcmpfel","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neucli.2017.02.004_bib1535","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"\u201cRating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)\u201d","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.neucli.2017.02.004_bib1540","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jneuroim.2006.03.001","article-title":"Interleukin-1 beta modulates AMPA receptor expression and phosphorylation in hippocampal neurons","volume":"175","author":"Lai","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1545","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00415-009-0152-7","article-title":"Modafinil effects in multiple sclerosis patients with fatigue","volume":"256","author":"Lange","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1550","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1191\/135248506ms1275oa","article-title":"Levocarnitine administration in multiple sclerosis patients with immunosuppressive therapy-induced fatigue","volume":"12","author":"Lebrun","year":"2006","journal-title":"Mult Scler"},{"key":"10.1016\/j.neucli.2017.02.004_bib1555","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1016\/j.clineuro.2013.09.029","article-title":"Evaluating the effects of amantadin, modafinil and acetyl-L-carnitine on fatigue in multiple sclerosis \u2013 result of a pilot randomized, blind study","volume":"115","author":"Ledinek","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.neucli.2017.02.004_bib1560","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/j.clinph.2014.05.021","article-title":"Evidence-based guidelines on the therapeutic use or repetitive transcranial magnetic stimulation (rTMS)","volume":"125","author":"Lefaucheur","year":"2014","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1565","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.clinph.2016.10.087","article-title":"Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS)","volume":"128","author":"Lefaucheur","year":"2017","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1570","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1111\/j.1468-1331.2007.01974.x","article-title":"A prospective study of patterns of fatigue in multiple sclerosis","volume":"14","author":"Lerdal","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1575","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1191\/1352458505ms1163oa","article-title":"Motor cortex excitability and fatigue in multiple sclerosis: a transcranial magnetic stimulation study","volume":"11","author":"Liepert","year":"2005","journal-title":"Mult Scler"},{"key":"10.1016\/j.neucli.2017.02.004_bib1580","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1053\/smrv.2000.0116","article-title":"Brain structures and mechanisms involved in the control of cortical activation and wakefulness, with emphasis on the posterior hypothalamus and histaminergic neurons","volume":"4","author":"Lin","year":"2000","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.neucli.2017.02.004_bib1585","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1093\/brain\/awn105","article-title":"Mitochondrial defects in acute multiple sclerosis lesions","volume":"131","author":"Mahad","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neucli.2017.02.004_bib1590","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1017\/cjn.2015.48","article-title":"Alemtuzumab induced thyroid disease in multiple sclerosis: a review and approach to management","volume":"42","author":"Mahzari","year":"2015","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.neucli.2017.02.004_bib1595","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s004150050382","article-title":"Fatigue and magnetic resonance imaging activity in multiple sclerosis","volume":"246","author":"Mainero","year":"1999","journal-title":"J Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1600","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1212\/01.WNL.0000129263.14219.A8","article-title":"Enhanced brain motor activity in patients with MS after a single dose of 3,4-diaminopyridine","volume":"62","author":"Mainero","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neucli.2017.02.004_bib1605","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/ajcn\/86.5.1738","article-title":"L-carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: a randomized and controlled clinical trial","volume":"86","author":"Malaguarnera","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.neucli.2017.02.004_bib1610","doi-asserted-by":"publisher","first-page":"758314","DOI":"10.1155\/2015\/758314","article-title":"Fatigue in patients with multiple sclerosis: is it related to pro- and anti-inflammatory cytokines?","volume":"2015","author":"Malekzadeh","year":"2015","journal-title":"Dis Markers"},{"key":"10.1016\/j.neucli.2017.02.004_bib1615","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1177\/1352458507080734","article-title":"Restless legs syndrome is a common finding in multiple sclerosis and correlates with cervical cord damage","volume":"14","author":"Manconi","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.neucli.2017.02.004_bib1620","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1043-6618(05)80117-3","article-title":"L-carnitine and carnitine ester transport in the rat small intestine","volume":"23","author":"Marciani","year":"1991","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.neucli.2017.02.004_bib1625","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jns.2004.11.046","article-title":"Association of fatigue and brain atrophy in multiple sclerosis","volume":"228","author":"Marrie","year":"2005","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neucli.2017.02.004_bib1630","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1177\/1352458514564487","article-title":"The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review","volume":"21","author":"Marrie","year":"2015","journal-title":"Mult Scler"},{"key":"10.1016\/j.neucli.2017.02.004_bib1635","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00401-013-1140-7","article-title":"HPA axis activity in multiple sclerosis correlates with disease severity, lesion type and gene expression in normal-appearing white matter","volume":"126","author":"Melief","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1640","first-page":"848","article-title":"Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function","volume":"79","author":"Michelson","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.neucli.2017.02.004_bib1645","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/ane.12557","article-title":"Whole-body cryostimulation (cryotherapy) provides benefits for fatigue and functional status in multiple sclerosis patients. A case-control study","volume":"134","author":"Miller","year":"2016","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.neucli.2017.02.004_bib1650","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/qjmed\/hcm122","article-title":"A medical definition of fatigue in multiple sclerosis","volume":"101","author":"Mills","year":"2008","journal-title":"QJM"},{"key":"10.1016\/j.neucli.2017.02.004_bib1655","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1096\/fj.07-099499","article-title":"Interferon-gamma directly induces neurotoxicity through a neuron specific, calcium-permeable complex of IFN-gamma receptor and AMPA GluR1 receptor","volume":"22","author":"Mizuno","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.neucli.2017.02.004_bib1660","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.neucli.2017.02.004_bib1665","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1177\/1352458511402410","article-title":"HAGIL (Hamburg vigil study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis","volume":"17","author":"M\u00f6ller","year":"2011","journal-title":"Mult Scler"},{"key":"10.1016\/j.neucli.2017.02.004_bib1670","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00415-010-5742-x","article-title":"Is central fatigue in multiple sclerosis a disorder of movement preparation?","volume":"258","author":"Morgante","year":"2011","journal-title":"J Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1675","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1136\/jnnp.72.3.361","article-title":"Changes in gait and fatigue from morning to afternoon in people with multiple sclerosis","volume":"72","author":"Morris","year":"2002","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.neucli.2017.02.004_bib1680","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1177\/1545968312437943","article-title":"Energy cost of walking and its association with gait parameters, daily activity, and fatigue in persons with mild multiple sclerosis","volume":"26","author":"Motl","year":"2012","journal-title":"Neurorehabil Neural Repair"},{"key":"10.1016\/j.neucli.2017.02.004_bib1685","doi-asserted-by":"publisher","first-page":"e0148997","DOI":"10.1371\/journal.pone.0148997","article-title":"Disability and fatigue can be objectively measured in multiple sclerosis","volume":"11","author":"Motta","year":"2016","journal-title":"Plos One"},{"key":"10.1016\/j.neucli.2017.02.004_bib1690","series-title":"Fatigue and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis","author":"Multiple sclerosis council for clinical practice guidelines","year":"1998"},{"key":"10.1016\/j.neucli.2017.02.004_bib1695","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1111\/j.1468-1331.2007.01882.x","article-title":"Prevalence of autoimmune thyroid disorders in a Spanish multiple sclerosis cohort","volume":"14","author":"Munteis","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1700","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1017\/S0317167100047107","article-title":"Amantadine therapy for fatigue in multiple sclerosis","volume":"12","author":"Murray","year":"1985","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.neucli.2017.02.004_bib1705","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jns.2014.03.024","article-title":"Modulation of alertness by sustained cognitive demand in MS as surrogate measure of fatigue and fatigability","volume":"340","author":"Neumann","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neucli.2017.02.004_bib1710","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1152\/jappl.2000.88.3.871","article-title":"Blunted pressor and intramuscular metabolic responses to voluntary isometric exercise in multiple sclerosis","volume":"88","author":"Ng","year":"2000","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.neucli.2017.02.004_bib1715","unstructured":"Nice clinical guidance 186. Management of multiple sclerosis in primary and secondary care; 2014."},{"key":"10.1016\/j.neucli.2017.02.004_bib1720","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1007\/s00415-006-0128-9","article-title":"Deep gray matter and fatigue in MS: a T1 relaxation time study","volume":"253","author":"Niepel","year":"2006","journal-title":"J Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1725","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1469-7793.2000.t01-1-00633.x","article-title":"Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation","volume":"527","author":"Nitsche","year":"2000","journal-title":"J Physiol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1730","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/bjsm.2003.010330","article-title":"From catastrophe to complexity: a novel model of integrative central neural regulation of effort and fatigue during exercise in humans: summary and conclusions","volume":"39","author":"Noakes","year":"2005","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.neucli.2017.02.004_bib1735","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.3109\/09638288.2012.738760","article-title":"Gait characteristics of multiple sclerosis patients in the absence of clinical disability","volume":"35","author":"Nogueira","year":"2013","journal-title":"Disabil Rehabil"},{"key":"10.1016\/j.neucli.2017.02.004_bib1740","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.msard.2015.10.006","article-title":"Longitudinal associations between brain structural changes and fatigue in early MS","volume":"5","author":"Nourbakhsh","year":"2016","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.neucli.2017.02.004_bib1745","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.pain.2007.08.024","article-title":"Pain associated with multiple sclerosis: systematic review and proposed classification","volume":"137","author":"O\u2019Connor","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.neucli.2017.02.004_bib1750","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s00415-004-0442-z","article-title":"Low CSF hypocretin-1\/orexin-A associated with hypersomnia secondary to hypothalamic lesion in a case of multiple sclerosis","volume":"251","author":"Oka","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1755","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.brs.2014.09.014","article-title":"Non-invasive brain stimulation therapy in multiple sclerosis: a review of tDCS, rTMS and ECT results","volume":"7","author":"Palm","year":"2014","journal-title":"Brain Stimul"},{"key":"10.1016\/j.neucli.2017.02.004_bib1760","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1177\/1352458513475490","article-title":"Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis","volume":"19","author":"Papadopoulou","year":"2013","journal-title":"Mult Scler"},{"key":"10.1016\/j.neucli.2017.02.004_bib1765","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3109\/09540261003589323","article-title":"The neuropsychiatry of multiple sclerosis: focus on disorders of mood, affect and behaviour","volume":"22","author":"Paparrigopoulos","year":"2010","journal-title":"Int Rev Psychiatry"},{"key":"10.1016\/j.neucli.2017.02.004_bib1770","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0028-3908(74)90009-4","article-title":"Amantadine may stimulate dopamine and noradrenaline receptors","volume":"13","author":"Papeschi","year":"1974","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neucli.2017.02.004_bib1775","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.neulet.2010.02.062","article-title":"CSF hypocretin-1 concentrations correlate with the level of fatigue in multiple sclerosis patients","volume":"474","author":"Papu\u0107","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neucli.2017.02.004_bib1780","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1037\/a0019585","article-title":"Frontal networks play a role in fatigue perception in multiple sclerosis","volume":"124","author":"Pardini","year":"2010","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.neucli.2017.02.004_bib1785","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1207\/s15324826an0503_5","article-title":"Cognitive and physical fatigue in multiple sclerosis: relations between self-report and objective performance","volume":"5","author":"Paul","year":"1998","journal-title":"Appl Neuropsychol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1790","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.clineuro.2015.08.023","article-title":"Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients","volume":"139","author":"Pavsic","year":"2015","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.neucli.2017.02.004_bib1795","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1001\/archneurol.2010.48","article-title":"Relationship of cortical atrophy to fatigue in patients with multiple sclerosis","volume":"67","author":"Pellicano","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1800","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1177\/1352458509348519","article-title":"The fatigue scale for motor and cognitive functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue","volume":"15","author":"Penner","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.neucli.2017.02.004_bib1805","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jns.2005.11.025","article-title":"Fatigue in multiple sclerosis is related to disability, depression and quality of life","volume":"243","author":"Pittion-Vouyovitch","year":"2006","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neucli.2017.02.004_bib1810","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000119325","article-title":"Amantadine and L-carnitine treatment of chronic fatigue syndrome","volume":"35","author":"Plioplys","year":"1997","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.neucli.2017.02.004_bib1815","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.clineuro.2012.02.048","article-title":"Stimulated peripheral production of interferon-gamma is related to fatigue and depression in multiple sclerosis","volume":"114","author":"Pokryszko-Dragan","year":"2012","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.neucli.2017.02.004_bib1820","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1007\/s10072-016-2622-x","article-title":"Event-related potentials and cognitive performance in multiple sclerosis patients with fatigue","volume":"37","author":"Pokryszko-Dragan","year":"2016","journal-title":"Neurol Sci"},{"key":"10.1016\/j.neucli.2017.02.004_bib1825","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1001\/archneur.1994.00540150090022","article-title":"4-aminopyridine in the treatment of patients with multiple sclerosis. Long-term efficacy and safety","volume":"51","author":"Polman","year":"1994","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1830","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1001\/archneur.1994.00540230074016","article-title":"4-aminopyridine is superior to 3,4-diaminopyridine in the treatment of patients with multiple sclerosis","volume":"51","author":"Polman","year":"1994","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1835","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.psyneuen.2015.03.010","article-title":"Circadian cortisol and fatigue severity in relapsing-remitting multiple sclerosis","volume":"56","author":"Powell","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neucli.2017.02.004_bib1840","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1177\/1352458515625806","article-title":"Hyperconnectivity of the dorsolateral prefrontal cortex following mental effort in multiple sclerosis patients with cognitive fatigue","volume":"22","author":"Pravat\u00e0","year":"2016","journal-title":"Mult Scler"},{"key":"10.1016\/j.neucli.2017.02.004_bib1845","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1600-0404.1999.tb00731.x","article-title":"A multidimensional assessment of multiple sclerosis: relationships between disability domains","volume":"100","author":"Provinciali","year":"1999","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.neucli.2017.02.004_bib1850","first-page":"75","article-title":"Assessing the long-term clinical benefit of prolonged-release fampridine tablets in a real-world setting: a review of 67\u00a0cases","volume":"4","author":"Prugger","year":"2013","journal-title":"Patient Relat Outcome Meas"},{"key":"10.1016\/j.neucli.2017.02.004_bib1855","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1152\/jn.1965.28.1.166","article-title":"Intracellular activities and evoked potential changes during polarization of motor cortex","volume":"28","author":"Purpura","year":"1965","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1860","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1136\/jnnp.72.2.179","article-title":"Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase\u00a02 study","volume":"72","author":"Rammohan","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neucli.2017.02.004_bib1865","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1093\/brain\/120.12.2149","article-title":"Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible","volume":"120","author":"Redford","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.neucli.2017.02.004_bib1870","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3174\/ajnr.A2412","article-title":"Voxelwise assessment of the regional distribution of damage in the brains of patients with multiple sclerosis and fatigue","volume":"32","author":"Riccitelli","year":"2011","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1875","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/hbm.20279","article-title":"fMRI changes in relapsing-remitting multiple sclerosis patients complaining of fatigue after IFNbeta-1a injection","volume":"28","author":"Rocca","year":"2007","journal-title":"Hum Brain Mapp"},{"key":"10.1016\/j.neucli.2017.02.004_bib1880","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s00415-009-0116-y","article-title":"Influence of task complexity during coordinated hand and foot movements in MS patients with and without fatigue. A kinematic and functional MRI study","volume":"256","author":"Rocca","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1885","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1148\/radiol.14140417","article-title":"Regional but not global brain damage contributes to fatigue in multiple sclerosis","volume":"273","author":"Rocca","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.neucli.2017.02.004_bib1890","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1212\/WNL.48.6.1566","article-title":"Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study","volume":"48","author":"Roelcke","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.neucli.2017.02.004_bib1895","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1001\/archneur.1988.00520340058012","article-title":"Amantadine, fatigue, and multiple sclerosis","volume":"45","author":"Rosenberg","year":"1988","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1900","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1542\/peds.101.5.921","article-title":"Four cases of severe hepatotoxicity associated with pemoline: possible autoimmune pathogenesis","volume":"101","author":"Rosh","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.neucli.2017.02.004_bib1905","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1191\/135245801701567050","article-title":"Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridine","volume":"7","author":"Rossini","year":"2001","journal-title":"Mult Scler"},{"key":"10.1016\/j.neucli.2017.02.004_bib1910","first-page":"182","article-title":"Double-blind, multicenter trial comparing acetyl l-carnitine with placebo in the treatment of fibromyalgia patients","volume":"25","author":"Rossini","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1915","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1007\/BF03348040","article-title":"Occurrence of thyroid autoimmunity and dysfunction throughout a 9-month follow-up in patients undergoing interferon-beta therapy for multiple sclerosis","volume":"21","author":"Rotondi","year":"1998","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.neucli.2017.02.004_bib1920","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/BF03343730","article-title":"Long-term treatment with interferon-beta therapy for multiple sclerosis and occurrence of Graves\u2019 disease","volume":"23","author":"Rotondi","year":"2000","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.neucli.2017.02.004_bib1925","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/BF00886876","article-title":"Patterns of disease activity in multiple sclerosis patients: a study with quantitative gadolinium enhanced brain MRI and cytokine measurement in different clinical subgroups","volume":"243","author":"Rovaris","year":"1996","journal-title":"J Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1930","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jns.2013.11.011","article-title":"Long-term effects of dalfampridine in patients with multiple sclerosis","volume":"337","author":"Ruck","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neucli.2017.02.004_bib1935","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1001\/archneur.1990.00530030018008","article-title":"Serum interleukin\u00a02 and soluble interleukin\u00a02 receptor in patients with multiple sclerosis who are experiencing severe fatigue","volume":"47","author":"Rudick","year":"1990","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1940","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s00415-010-5821-z","article-title":"Assessment of gait parameters and fatigue in MS patients during inpatient rehabilitation: a pilot trial","volume":"258","author":"Sacco","year":"2011","journal-title":"J Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1945","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1097\/00004583-200106000-00006","article-title":"Pemoline hepatotoxicity and postmarketing surveillance","volume":"40","author":"Safer","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.neucli.2017.02.004_bib1950","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1186\/s40064-016-2776-2","article-title":"Fampridine and quality of life in individuals with multiple sclerosis","volume":"5","author":"Sagawa","year":"2016","journal-title":"Springerplus"},{"key":"10.1016\/j.neucli.2017.02.004_bib1955","first-page":"423","article-title":"Impact of transcranial direct current stimulation on fatigue in multiple sclerosis","volume":"32","author":"Saiote","year":"2014","journal-title":"Restor Neurol Neurosci"},{"key":"10.1016\/j.neucli.2017.02.004_bib1960","first-page":"162765","article-title":"Oxygen cost of walking in persons with multiple sclerosis: disability matters, but why?","volume":"2014","author":"Sandroff","year":"2014","journal-title":"Mult Scler Int"},{"key":"10.1016\/j.neucli.2017.02.004_bib1965","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3389\/fneur.2014.00214","article-title":"Subjective cognitive fatigue in multiple sclerosis depends on task length","volume":"5","author":"Sandry","year":"2014","journal-title":"Front Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1970","doi-asserted-by":"publisher","first-page":"616242","DOI":"10.1155\/2015\/616242","article-title":"Neurophysiological correlates of central fatigue in healthy subjects and multiple sclerosis patients before and after treatment with amantadine","volume":"2015","author":"Santarnecchi","year":"2015","journal-title":"Neural Plast"},{"key":"10.1016\/j.neucli.2017.02.004_bib1975","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1001\/archneur.60.8.1082","article-title":"Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid","volume":"60","author":"Sarchielli","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1980","doi-asserted-by":"crossref","first-page":"8620","DOI":"10.1523\/JNEUROSCI.20-22-08620.2000","article-title":"Hypothalamic arousal regions are activated during modafinil-induced wakefulness","volume":"20","author":"Scammell","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.neucli.2017.02.004_bib1985","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0014-2999(70)90194-9","article-title":"Increased synthesis and release of dopamine in the striatum of the rat after amantadine treatment","volume":"13","author":"Scatton","year":"1970","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neucli.2017.02.004_bib1990","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/0022-3999(93)90104-N","article-title":"The measurement of fatigue: a new instrument","volume":"37","author":"Schwartz","year":"1993","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.neucli.2017.02.004_bib1995","first-page":"S38","article-title":"Quantifying fatigue severity with a visual analog diary","volume":"5","author":"Schwid","year":"1999","journal-title":"Mult Scler"},{"key":"10.1016\/j.neucli.2017.02.004_bib2000","first-page":"211","article-title":"Fatigue in multiple sclerosis: current understanding and future directions","volume":"39","author":"Schwid","year":"2002","journal-title":"J Rehabil Res Dev"},{"key":"10.1016\/j.neucli.2017.02.004_bib2005","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1177\/1352458508098373","article-title":"Fatigue in multiple sclerosis is associated with the disruption of frontal and parietal pathways","volume":"15","author":"Sepulcre","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.neucli.2017.02.004_bib2010","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1002\/mus.880181210","article-title":"Evidence of an abnormal intramuscular component of fatigue in multiple sclerosis","volume":"18","author":"Sharma","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neucli.2017.02.004_bib2015","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1179\/1743132812Y.0000000081","article-title":"Comparison of the effect of aspirin and amantadine for the treatment of fatigue in multiple sclerosis: a randomized, blinded, crossover study","volume":"34","author":"Shaygannejad","year":"2012","journal-title":"Neurol Res"},{"key":"10.1016\/j.neucli.2017.02.004_bib2020","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/brain\/120.2.299","article-title":"An electrophysiological study of the mechanism of fatigue in multiple sclerosis","volume":"120","author":"Sheean","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.neucli.2017.02.004_bib2025","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1093\/brain\/121.5.967","article-title":"An open-labelled clinical and electrophysiological study of 3,4\u00a0diaminopyridine in the treatment of fatigue in multiple sclerosis","volume":"121","author":"Sheean","year":"1998","journal-title":"Brain"},{"key":"10.1016\/j.neucli.2017.02.004_bib2030","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1152\/jn.1998.79.2.529","article-title":"Nerve conduction block by nitric oxide that is mediated by the axonal environment","volume":"79","author":"Shrager","year":"1998","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.neucli.2017.02.004_bib2035","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/brain\/123.1.171","article-title":"Effects of 4-aminopyridine on demyelinated axons, synapses and muscle tension","volume":"123","author":"Smith","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.neucli.2017.02.004_bib2040","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1007\/s11547-012-0845-3","article-title":"Functional MRI during the execution of a motor task in patients with multiple sclerosis and fatigue","volume":"117","author":"Specogna","year":"2012","journal-title":"Radiol Med"},{"key":"10.1016\/j.neucli.2017.02.004_bib2045","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1093\/brain\/awh467","article-title":"Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3T","volume":"128","author":"Srinivasan","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.neucli.2017.02.004_bib2050","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1212\/01.WNL.0000158272.27070.6A","article-title":"Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study","volume":"64","author":"Stankoff","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neucli.2017.02.004_bib2055","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1191\/135248506ms1320oa","article-title":"Sleep and fatigue in multiple sclerosis","volume":"12","author":"Stanton","year":"2006","journal-title":"Mult Scler"},{"key":"10.1016\/j.neucli.2017.02.004_bib2060","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/ana.410210113","article-title":"4-aminopyridine improves clinical signs in multiple sclerosis","volume":"21","author":"Stefoski","year":"1987","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib2065","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1212\/WNL.41.9.1344","article-title":"4-aminopyridine in multiple sclerosis: prolonged administration","volume":"41","author":"Stefoski","year":"1991","journal-title":"Neurology."},{"key":"10.1016\/j.neucli.2017.02.004_bib2070","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1523\/JNEUROSCI.4486-04.2005","article-title":"Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha","volume":"25","author":"Stellwagen","year":"2005","journal-title":"J Neurosci."},{"key":"10.1016\/j.neucli.2017.02.004_bib2075","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0304-3940(97)00840-9","article-title":"Cerebrospinal fluid hypoxanthine, xanthine and uric acid levels may reflect glutamate-mediated excitotoxicity in different neurological diseases","volume":"238","author":"Stover","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neucli.2017.02.004_bib2080","first-page":"2","article-title":"Sleep changes in multiple sclerosis (MS): from the individual's perspective","author":"Strober","year":"2013","journal-title":"J Sleep Disord Treat Care"},{"key":"10.1016\/j.neucli.2017.02.004_bib2085","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jns.2005.03.031","article-title":"General mechanisms of axonal damage and its prevention","volume":"233","author":"Stys","year":"2005","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neucli.2017.02.004_bib2090","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/0006-8993(85)91049-2","article-title":"4-aminopyridine leads to restoration of conduction in demyelinated rat sciatic nerve","volume":"328","author":"Targ","year":"1985","journal-title":"Brain Res"},{"key":"10.1016\/j.neucli.2017.02.004_bib2095","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1001\/archneur.61.2.201","article-title":"The relationship between diffuse axonal damage and fatigue in multiple sclerosis","volume":"61","author":"Tartaglia","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib2100","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1468-1331.2008.02090.x","article-title":"Mental fatigue alters the pattern and increases the volume of cerebral activation required for a motor task in multiple sclerosis patients with fatigue","volume":"15","author":"Tartaglia","year":"2008","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib2105","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1007\/s00415-014-7377-9","article-title":"Multiple sclerosis fatigue relief by bilateral somatosensory cortex neuromodulation","volume":"261","author":"Tecchio","year":"2014","journal-title":"J Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib2110","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3389\/fneur.2015.00141","article-title":"Brain plasticity effects of neuromodulation against multiple sclerosis fatigue","volume":"6","author":"Tecchio","year":"2015","journal-title":"Front Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib2115","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jns.2007.07.004","article-title":"Correlation between fatigue and brain atrophy and lesion load in multiple sclerosis patients independent of disability","volume":"263","author":"Tedeschi","year":"2007","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neucli.2017.02.004_bib2120","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00234-007-0304-3","article-title":"The basal ganglia: a substrate for fatigue in multiple sclerosis","volume":"50","author":"T\u00e9llez","year":"2008","journal-title":"Neuroradiology"},{"key":"10.1016\/j.neucli.2017.02.004_bib2125","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1017\/S0317167100026603","article-title":"A randomized controlled trial of amantadine in fatigue associated with multiple sclerosis","volume":"14","author":"The Canadian MS research group","year":"1987","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.neucli.2017.02.004_bib2130","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1212\/WNL.53.4.772","article-title":"Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS","volume":"53","author":"Then Bergh","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neucli.2017.02.004_bib2135","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jns.2003.11.005","article-title":"Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial","volume":"218","author":"Tomassini","year":"2004","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neucli.2017.02.004_bib2140","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fnbeh.2013.00028","article-title":"Role of orexin in modulating arousal, feeding, and motivation","volume":"7","author":"Tsujino","year":"2013","journal-title":"Front Behav Neurosci"},{"key":"10.1016\/j.neucli.2017.02.004_bib2145","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/ana.410430115","article-title":"Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy","volume":"43","author":"US modafinil in narcolepsy multicenter study group","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib2150","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1212\/WNL.54.5.1166","article-title":"Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy","volume":"54","author":"US modafinil in narcolepsy multicenter study group","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neucli.2017.02.004_bib2155","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jpsychores.2016.09.002","article-title":"Effectiveness of cognitive behavioral therapy for the treatment of fatigue in patients with multiple sclerosis: a systematic review and meta-analysis","volume":"90","author":"Van den Akker","year":"2016","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.neucli.2017.02.004_bib2160","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0022-510X(98)00251-2","article-title":"Fatigue in multiple sclerosis: interrelations between fatigue complaints, cerebral MRI abnormalities and neurological disability","volume":"160","author":"Van der Werf","year":"1998","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neucli.2017.02.004_bib2165","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/ana.410320203","article-title":"The effect of 4-aminopyridine on clinical signs in multiple sclerosis: a randomized, placebo-controlled, double-blind, cross-over study","volume":"32","author":"Van Diemen","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib2170","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/00002826-199306000-00002","article-title":"4-aminopyridine in patients with multiple sclerosis: dosage and serum level related to efficacy and safety","volume":"16","author":"Van Diemen","year":"1993","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.neucli.2017.02.004_bib2175","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.gaitpost.2010.09.002","article-title":"Postural control in women with multiple sclerosis: effects of task, vision and symptomatic fatigue","volume":"32","author":"Van Emmerik","year":"2010","journal-title":"Gait Posture"},{"key":"10.1016\/j.neucli.2017.02.004_bib2180","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0022-3999(94)90099-X","article-title":"Dimensional assessment of chronic fatigue syndrome","volume":"38","author":"Vercoulen","year":"1994","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.neucli.2017.02.004_bib2185","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1001\/archneur.1996.00550070080014","article-title":"The measurement of fatigue in patients with multiple sclerosis: a multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects","volume":"53","author":"Vercoulen","year":"1996","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib2190","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/nrn2023","article-title":"Axonal conduction and injury in multiple sclerosis: the role of sodium channels","volume":"7","author":"Waxman","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neucli.2017.02.004_bib2195","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1212\/WNL.42.8.1468","article-title":"A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis","volume":"42","author":"Weinshenker","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.neucli.2017.02.004_bib2200","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1017\/S1121189X00007089","article-title":"The epidemiology of chronic fatigue syndrome","volume":"7","author":"Wessely","year":"1998","journal-title":"Epidemiol Psichiatr Soc"},{"key":"10.1016\/j.neucli.2017.02.004_bib2205","unstructured":"WHO Pharmaceuticals Newsletter. Pemoline-Withdrawn due to liver toxicity risk. (05). 2005."},{"key":"10.1016\/j.neucli.2017.02.004_bib2210","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1212\/01.WNL.0000156803.23698.9A","article-title":"A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis","volume":"64","author":"Wingerchuk","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neucli.2017.02.004_bib2215","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1007\/s00415-011-6091-0","article-title":"Fatigue and progression of corpus callosum atrophy in multiple sclerosis","volume":"258","author":"Yaldizli","year":"2011","journal-title":"J Neurol"},{"key":"10.1016\/j.neucli.2017.02.004_bib2220","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1177\/1352458513496880","article-title":"The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients","volume":"20","author":"Yaldizli","year":"2014","journal-title":"Mult Scler"},{"key":"10.1016\/j.neucli.2017.02.004_bib2225","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1212\/01.wnl.0000336918.32695.6b","article-title":"Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis","volume":"71","author":"Ysrraelit","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neucli.2017.02.004_bib2230","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1177\/1352458509350306","article-title":"Hypothalamic involvement assessed by T1 relaxation time in patients with relapsing-remitting multiple sclerosis","volume":"15","author":"Zellini","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.neucli.2017.02.004_bib2235","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s00415-002-0765-6","article-title":"Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study","volume":"249","author":"Zifko","year":"2002","journal-title":"J Neurol"}],"container-title":["Neurophysiologie Clinique\/Clinical Neurophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0987705316303847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0987705316303847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T23:30:27Z","timestamp":1601940627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0987705316303847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":248,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0987705316303847"],"URL":"https:\/\/doi.org\/10.1016\/j.neucli.2017.02.004","relation":{},"ISSN":["0987-7053"],"issn-type":[{"value":"0987-7053","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fatigue in multiple sclerosis \u2013 Insights into evaluation and management","name":"articletitle","label":"Article Title"},{"value":"Neurophysiologie Clinique\/Clinical Neurophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neucli.2017.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}